Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04507139 · ClinicalTrials.gov registry record
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
A clinical trial of Parkinson Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Active
- Registry status
- 50
- Enrollment target
- 3
- Study locations
NCT04507139 is a study of Parkinson Disease that is active but no longer recruiting, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 50 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04507139, a study of Parkinson Disease, is active but no longer recruiting, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
Directly examine whether early (6-month) imaging with DaTscan and \[¹⁸F\] AV-133 will provide an early signal of disease progression in recently diagnosed untreated PD patients.
Conditions Studied
Study Locations (3)
Connecticut
- Institute For Neurodegenerative Disorders - New Haven
Massachusetts
- Boston University Medical Center - Boston
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04507139
The ClinicalTrials.gov registry entry for NCT04507139 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04507139 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04507139 about?
NCT04507139 is a clinical study titled "Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™". Directly examine whether early (6-month) imaging with DaTscan and \[¹⁸F\] AV-133 will provide an early signal of disease progression in recently diagnosed untreated PD patients.
What is the current status of trial NCT04507139?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2020-09-10. Estimated completion is 2025-06.
What conditions does trial NCT04507139 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT04507139?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04507139 being conducted?
This trial has 3 study locations across Connecticut, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.